Position in ALMS
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$242,396
+$135,007 QoQ
Shares Held
11,003
0.0% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ALMS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Kera Capital Partners, Inc. holds $3,712,879 across 11 Biotechnology names. ALMS ranks #7 (6.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KYTX |
Kyverna Therapeutics, Inc.
|
108,083 | $932,756 | |
| 2 | INCY |
Incyte Corp
|
6,755 | $635,780 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
593 | $458,175 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
2,165 | $409,293 | |
| 5 | PHAT |
Phathom Pharmaceuticals, Inc.
|
26,826 | $298,036 | |
| 6 | TECH |
BIO-TECHNE Corp
|
4,679 | $244,524 | |
| 7 | ALMS |
Alumis Inc.
This page
|
11,003 | $242,396 | |
| 8 | FDMT |
4D Molecular Therapeutics, Inc.
|
24,068 | $224,073 |
All Filings in ALMS
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $242,396 | 11,003 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $107,389 | 11,003 | Shares | Sole | 2026-02-23 | |
| 2025-09-30 | $43,798 | 10,977 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $31,578 | 10,526 | Shares | Sole | 2025-07-01 | |
| No filing history on record for this holder in this stock. | ||||||